Abstract:Objective Macrophages crosstalk with oxidised low-density lipoprotein (oxLDL), play a critical role in the initiation, progression and subsequent stability of atherosclerotic plaques. Statins, inhibitors of HMG CoA (3-hydroxy-3-methylglutaryl coenzyme A) reductase, reduce the expression of inflammatory proteins in addition to their lipid-lowering action. However, the effect and the detailed anti-inflammation mechanisms of statins in macrophages induced by oxLDL remain unclear. In the present study, we investigated the effect of atorvastatin on inflammatory response upon oxLDL stimulation in murine macrophages and analysed the underlying mechanisms. Methods Raw 264.7 macrophages were cultured and pre-treated with varying doses of atorvastatin in the absence or presence of 40 μg/ml oxLDL. The morphology of the cells was observed and the expression of inflammatory cytokines such as monocyte chemoattractant protein-1 (MCP-1) and tumour necrosis factor (TNF) was assayed by real-time PCR. The expression of Cyclooxygenases -2(COX-2) was performed by real-time PCR and Western blotting. MAPK phosphorylation and IκBa degradation were determined by Western blotting. After pre-incubation with atorvastatin or PD98059, inhibitor of ERK1/2 MAPK, the expression of COX-2 was also detected by real-time PCR and Western blotting. Results Our findings have shown that exposure of RAW264.7 cells to oxLDL, substantially changed the morphology of the cells and increased the mRNA expression of proinflammatory cytokines and chemokines including TNFa and MCP-1, approximately to 14-fold, 10-fold, respectively while pretreatment with atorvastatin resulted in a significant inhibition of the oxLDL-induced morphological alteration and inflammatory cytokines expression in a dose-dependent fashion. Further investigation of the molecular mechanism revealed that oxLDL upregulated the transcription and protein expression of COX-2 in a time-dependent manner. Moreover, the activation of ERK pathway and IκBa degradation contribute to this effect. Conclusions Taken together, the anti-inflammatory effect of atorvastatin is mediated through the inhibition of proinflammatory COX-2. Furthermore, suppression of ERK phosphorylation and IκBa degradation is involved in this regulation. Our findings provide novel evidence that statins suppress inflammatory response in murine macrophages induced by oxLDL, exert its anti-atherogenic actions via against inflammation beyond cholesterol-lowering effect.

Fluvastatin Prevents Oxidized Low-Density Lipoprotein-Induced Injury of Renal Tubular Epithelial Cells by Inhibiting the Phosphatidylinositol 3-Kinase/akt-signaling Pathway

Oxidized High-Density Lipoprotein Enhances Inflammatory Activity in Rat Mesangial Cells

Statins Contribute to Enhancement of the Number and the Function of Endothelial Progenitor Cells from Peripheral Blood

Oxidized High-Density Lipoprotein Impairs The Function Of Human Renal Proximal Tubule Epithelial Cells Through Cd36

Regulation of Connexin Expression after Balloon Injury: Possible Mechanisms for Antiproliferative Effect of Statins.

[Influence of fluvastatin on left ventricular remodeling after myocardial infarction in rats].

Novel function of fluvastatin in attenuating oxidized low-density lipoprotein-induced endothelial cell ferroptosis in a glutathione peroxidase4- and cystine-glutamate antiporter-dependent manner

Fluvastatin inhibits advanced glycation end products-induced proliferation, migration, and extracellular matrix accumulation in vascular smooth muscle cells by targeting connective tissue growth factor

Short-Term and Long-Term Fluvastatin Inhibit Effects of Thrombospondin-1 on Human Vascular Smooth Muscle Cells

Nanoparticle-mediated Klotho Gene Therapy Prevents Acute Kidney Injury to Chronic Kidney Disease Transition Through Regulating PPARα Signaling in Renal Tubular Epithelial Cells

Inhibition of major histocompatibility complex classⅡexpression in endothelial cells by fluvastatin

Atorvastatin reduces contrast media-induced pyroptosis of renal tubular epithelial cells by inhibiting the TLR4/MyD88/NF-κB signaling pathway

Overexpression of sFlt-1 represses ox-LDL-induced injury of HUVECs by activating autophagy via PI3K/AKT/mTOR pathway

E0070 Atorvastatin Suppresses Inflammatory Response Induced by Oxldl Through Inhibition of ERK Phosphorylation, IκB? Degradation and COX-2 Expression in Murine Macrophages

Fluvastatin attenuated ischemia/reperfusion-induced autophagy and apoptosis in cardiomyocytes through down-regulation HMGB1/TLR4 signaling pathway

Simvastatin abates development of renal fibrosis in experimental renovascular disease

Antioxidative effects of fluvastatin and its metabolites against oxidative DNA damage in mammalian cultured cells

Synergistic Effects of Pravastatin and Pioglitazone in Renal Tubular Epithelial Cells Induced by Transforming Growth Factor‐β1

Ox‐LDL aggravates contrast‐induced injury of renal tubular epithelial cells

Activation of the Nrf2/ARE signaling pathway ameliorates hyperlipidemia-induced renal tubular epithelial cell injury by inhibiting mtROS-mediated NLRP3 inflammasome activation

Mitochondrial oxidative damage reprograms lipid metabolism of renal tubular epithelial cells in the diabetic kidney